Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 652035, 10 pages
http://dx.doi.org/10.1155/2015/652035
Review Article

Leukocytes: The Double-Edged Sword in Fibrosis

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland

Received 18 June 2015; Accepted 25 August 2015

Academic Editor: Pilar Alcaide

Copyright © 2015 Jakub Kryczka and Joanna Boncela. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound repair and regeneration,” Nature, vol. 453, no. 7193, pp. 314–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Chen, M. E. Schrementi, M. J. Ranzer, T. A. Wilgus, and L. A. DiPietro, “Blockade of mast cell activation reduces cutaneous scar formation,” PLoS ONE, vol. 9, no. 1, Article ID e85226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Bielefeld, S. Amini-Nik, and B. A. Alman, “Cutaneous wound healing: recruiting developmental pathways for regeneration,” Cellular and Molecular Life Sciences, vol. 70, no. 12, pp. 2059–2081, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Takuwa, H. Ikeda, Y. Okamoto, N. Takuwa, and K. Yoshioka, “Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1831, no. 1, pp. 185–192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. A. Jimenez, “Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis,” ISRN Rheumatology, vol. 2013, Article ID 835948, 15 pages, 2013. View at Publisher · View at Google Scholar
  6. A. Kill, C. Tabeling, R. Undeutsch et al., “Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis,” Arthritis Research and Therapy, vol. 16, article R29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. T. A. Wynn, “Fibrotic disease and the TH1/TH2 paradigm,” Nature Reviews Immunology, vol. 4, no. 8, pp. 583–594, 2004. View at Publisher · View at Google Scholar
  8. T. A. Wynn, “Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 524–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K.-M. T. Pu, P. Sava, and A. L. Gonzalez, “Microvascular targets for anti-fibrotic therapeutics,” Yale Journal of Biology and Medicine, vol. 86, no. 4, pp. 537–554, 2013. View at Google Scholar · View at Scopus
  10. M. J. Portou, D. Baker, D. Abraham, and J. Tsui, “The innate immune system, toll-like receptors and dermal wound healing: a review,” Vascular Pharmacology, vol. 71, pp. 31–36, 2015. View at Publisher · View at Google Scholar
  11. I. A. Darby, B. Laverdet, F. Bonté, and A. Desmoulière, “Fibroblasts and myofibroblasts in wound healing,” Clinical, Cosmetic and Investigational Dermatology, vol. 7, pp. 301–311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Werner and R. Grose, “Regulation of wound healing by growth factors and cytokines,” Physiological Reviews, vol. 83, no. 3, pp. 835–870, 2003. View at Google Scholar · View at Scopus
  13. D. D. Lo, A. S. Zimmermann, A. Nauta, M. T. Longaker, and H. P. Lorenz, “Scarless fetal skin wound healing update,” Birth Defects Research–Part C: Embryo Today: Reviews, vol. 96, no. 3, pp. 237–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” The Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Y. A. El-Aarag, T. Kasai, M. A. H. Zahran et al., “In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs,” International Immunopharmacology, vol. 21, no. 2, pp. 283–292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Lee, N. K. Decker, S. Chatterjee, J. Yao, S. Friedman, and V. Shah, “Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts,” The American Journal of Pathology, vol. 166, no. 6, pp. 1861–1870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Wietecha and L. A. DiPietro, “Therapeutic approaches to the regulation of wound angiogenesis,” Advances in Wound Care, vol. 2, no. 3, pp. 81–86, 2013. View at Publisher · View at Google Scholar
  18. B. Hinz and G. Gabbiani, “Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling,” Thrombosis and Haemostasis, vol. 90, no. 6, pp. 993–1002, 2003. View at Google Scholar · View at Scopus
  19. A. Desmoulière, M. Redard, I. Darby, and G. Gabbiani, “Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar,” American Journal of Pathology, vol. 146, no. 1, pp. 56–66, 1995. View at Google Scholar · View at Scopus
  20. A. Pardo and M. Selman, “Role of matrix metaloproteases in idiopathic pulmonary fibrosis,” Fibrogenesis and Tissue Repair, vol. 5, no. 1, article S9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Sargent, A. Milano, S. Bhattacharyya et al., “A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity,” Journal of Investigative Dermatology, vol. 130, no. 3, pp. 694–705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Wu, D. J. Schneider, M. D. Mayes et al., “Osteopontin in systemic sclerosis and its role in dermal fibrosis,” Journal of Investigative Dermatology, vol. 132, no. 6, pp. 1605–1614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Nikolic-Paterson, “CD4+ T cells: a potential player in renal fibrosis,” Kidney International, vol. 78, no. 4, pp. 333–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Mancini, L. Stutts, T. Moore, and A. P. Esser-Kahn, “Controlling the origins of inflammation with a photoactive lipopeptide immunopotentiator,” Angewandte Chemie International Edition, vol. 54, no. 20, pp. 5962–5965, 2015. View at Publisher · View at Google Scholar
  25. P. Bainbridge, “Wound healing and the role of fibroblasts,” Journal of Wound Care, vol. 22, no. 8, pp. 407–412, 2013. View at Publisher · View at Google Scholar
  26. R. Bucala, L. A. Spiegel, J. Chesney, M. Hogan, and A. Cerami, “Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair,” Molecular Medicine, vol. 1, no. 1, pp. 71–81, 1994. View at Google Scholar · View at Scopus
  27. E. L. Herzog and R. Bucala, “Fibrocytes in health and disease,” Experimental Hematology, vol. 38, no. 7, pp. 548–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Thiery, H. Acloque, R. Y. J. Huang, and M. A. Nieto, “Epithelial-mesenchymal transitions in development and disease,” Cell, vol. 139, no. 5, pp. 871–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Medici, E. M. Shore, V. Y. Lounev, F. S. Kaplan, R. Kalluri, and B. R. Olsen, “Conversion of vascular endothelial cells into multipotent stem-like cells,” Nature Medicine, vol. 16, pp. 1400–1406, 2010. View at Publisher · View at Google Scholar
  30. C.-H. Heldin, M. Vanlandewijck, and A. Moustakas, “Regulation of EMT by TGFβ in cancer,” FEBS Letters, vol. 586, no. 14, pp. 1959–1970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Marchiando, W. V. Graham, and J. R. Turner, “Epithelial barriers in homeostasis and disease,” Annual Review of Pathology: Mechanisms of Disease, vol. 5, pp. 119–144, 2010. View at Publisher · View at Google Scholar
  32. J. Fuxe and M. C. I. Karlsson, “TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation,” Seminars in Cancer Biology, vol. 22, no. 5-6, pp. 455–461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. E. Bear and J. M. Haugh, “Directed migration of mesenchymal cells: where signaling and the cytoskeleton meet,” Current Opinion in Cell Biology, vol. 30, no. 1, pp. 74–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. R. R. Markwald, T. P. Fitzharris, and F. J. Manasek, “Structural development of endocardial cushions,” American Journal of Anatomy, vol. 148, no. 1, pp. 85–119, 1977. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Krenning, E. M. Zeisberg, and R. Kalluri, “The origin of fibroblasts and mechanism of cardiac fibrosis,” Journal of Cellular Physiology, vol. 225, no. 3, pp. 631–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Zeisberg and R. Kalluri, “Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis,” American Journal of Physiology—Cell Physiology, vol. 304, no. 3, pp. C216–C225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Ubil, J. Duan, I. C. L. Pillai et al., “Mesenchymal-endothelial transition contributes to cardiac neovascularization,” Nature, vol. 514, no. 7524, pp. 585–590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Rieder, S. P. Kessler, G. A. West et al., “Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis,” The American Journal of Pathology, vol. 179, no. 5, pp. 2660–2673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. G. Lee, M. K. Ko, and E. P. Kay, “Endothelial mesenchymal transformation mediated by IL-1β-induced FGF-2 in corneal endothelial cells,” Experimental Eye Research, vol. 95, no. 1, pp. 35–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Dave, S. Guaita-Esteruelas, S. Gutarra et al., “Functional cooperation between snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition,” The Journal of Biological Chemistry, vol. 286, no. 14, pp. 12024–12032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Saito, “EMT and EndMT: regulated in similar ways?” Journal of Biochemistry, vol. 153, no. 6, pp. 493–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Lan, H. Han, H. Zuo et al., “Upregulation of myosin Va by snail is involved in cancer cell migration and metastasis,” International Journal of Cancer, vol. 126, no. 1, pp. 53–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Fan, S. Samuel, K. W. Evans et al., “Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells,” Cancer Medicine, vol. 1, no. 1, pp. 5–16, 2012. View at Publisher · View at Google Scholar
  44. T. Kokudo, Y. Suzuki, Y. Yoshimatsu, T. Yamazaki, T. Watabe, and K. Miyazono, “Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells,” Journal of Cell Science, vol. 121, no. 20, pp. 3317–3324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S.-W. Lee, J.-Y. Won, W. J. Kim et al., “Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis,” Molecular Therapy, vol. 21, no. 9, pp. 1767–1777, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Medici and R. Kalluri, “Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype,” Seminars in Cancer Biology, vol. 22, no. 5-6, pp. 379–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. A. K. Ghosh, V. Nagpal, J. W. Covington, M. A. Michaels, and D. E. Vaughan, “Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT,” Cellular Signalling, vol. 24, no. 5, pp. 1031–1036, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Lu and J. T. Corwin, “The influence of glycogen synthase kinase 3 in limiting cell addition in the mammalian ear,” Developmental Neurobiology, vol. 68, no. 8, pp. 1059–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. B. P. Zhou, J. Deng, W. Xia et al., “Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition,” Nature Cell Biology, vol. 6, no. 10, pp. 931–940, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Maleszewska, J.-R. A. J. Moonen, N. Huijkman, B. van de Sluis, G. Krenning, and M. C. Harmsen, “IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner,” Immunobiology, vol. 218, no. 4, pp. 443–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Chaudhuri, L. Zhou, and M. Karasek, “Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis,” Journal of Cutaneous Pathology, vol. 34, no. 2, pp. 146–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Moustakas and C.-H. Heldin, “Induction of epithelial-mesenchymal transition by transforming growth factor β,” Seminars in Cancer Biology, vol. 22, no. 5-6, pp. 446–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Lakos, S. Takagawa, S.-J. Chen et al., “Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma,” American Journal of Pathology, vol. 165, no. 1, pp. 203–217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. L. A. Borthwick, E. I. McIlroy, M. R. Gorowiec et al., “Inflammation and epithelial to mesenchymal transition in lung transplant recipients: role in dysregulated epithelial wound repair,” American Journal of Transplantation, vol. 10, no. 3, pp. 498–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. W. Hwang, M. Yang, M. Tsai et al., “SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells,” Gastroenterology, vol. 141, no. 1, pp. 279.e5–291.e5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. K. E. Hoot, J. Lighthall, G. Han et al., “Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression,” The Journal of Clinical Investigation, vol. 118, no. 8, pp. 2722–2732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J.-R. A. J. Moonen, G. Krenning, M. G. L. Brinker, J. A. Koerts, M. J. A. Van Luyn, and M. C. Harmsen, “Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny,” Cardiovascular Research, vol. 86, no. 3, pp. 506–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Thomson, F. Petti, I. Sujka-Kwok et al., “A systems view of epithelial-mesenchymal transition signaling states,” Clinical and Experimental Metastasis, vol. 28, no. 2, pp. 137–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. D. G. Downey, S. C. Bell, and J. S. Elborn, “Neutrophils in cystic fibrosis,” Thorax, vol. 64, no. 1, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. O. O. Olutoye, X. Zhu, D. L. Cass, and C. W. Smith, “Neutrophil recruitment by fetal porcine endothelial cells: implications in scarless fetal wound healing,” Pediatric Research, vol. 58, no. 6, pp. 1290–1294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Satish and S. Kathju, “Cellular and molecular characteristics of scarless versus fibrotic wound healing,” Dermatology Research and Practice, vol. 2010, Article ID 790234, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Nakamura, K. Yoshimura, N. G. McElvaney, and R. G. Crystal, “Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line,” The Journal of Clinical Investigation, vol. 89, no. 5, pp. 1478–1484, 1992. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Li, S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh, “IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis,” The Journal of Immunology, vol. 170, no. 6, pp. 3369–3376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Bakele, A. S. Lotz-Havla, A. Jakowetz et al., “An interactive network of elastase, secretases, and PAR-2 protein regulates CXCR1 receptor surface expression on neutrophils,” The Journal of Biological Chemistry, vol. 289, no. 30, pp. 20516–20525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. R. B. Fick Jr., R. A. Robbins, S. U. Squier, W. E. Schoderbek, and W. D. Russ, “Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity,” Pediatric Research, vol. 20, no. 12, pp. 1258–1268, 1986. View at Publisher · View at Google Scholar · View at Scopus
  66. A. M. Cantin, S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal, “Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis,” The Journal of Clinical Investigation, vol. 79, no. 6, pp. 1665–1673, 1987. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Worlitzsch, G. Herberth, M. Ulrich, and G. Döring, “Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis,” European Respiratory Journal, vol. 11, no. 2, pp. 377–383, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. H. H. Arnardottir, J. Freysdottir, and I. Hardardottir, “Two circulating neutrophil populations in acute inflammation in mice,” Inflammation Research, vol. 61, no. 9, pp. 931–939, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. K. R. Kasten, J. T. Muenzer, and C. C. Caldwell, “Neutrophils are significant producers of IL-10 during sepsis,” Biochemical and Biophysical Research Communications, vol. 393, no. 1, pp. 28–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Pillay, V. M. Kamp, E. van Hoffen et al., “A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1,” The Journal of Clinical Investigation, vol. 122, no. 1, pp. 327–336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. O. J. McElvaney, N. O'Reilly, M. White et al., “The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis,” Molecular Immunology, vol. 63, no. 2, pp. 550–558, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. J. C. Schupp, H. Binder, B. Jäger et al., “Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis,” PLoS ONE, vol. 10, no. 1, Article ID e0116775, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Griese, M. Kappler, A. Gaggar, and D. Hartl, “Inhibition of airway proteases in cystic fibrosis lung disease,” European Respiratory Journal, vol. 32, no. 3, pp. 783–795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar
  75. V. A. Fadok, D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson, “Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF,” The Journal of Clinical Investigation, vol. 101, no. 4, pp. 890–898, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Sanjabi, L. A. Zenewicz, M. Kamanaka, and R. A. Flavell, “Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity,” Current Opinion in Pharmacology, vol. 9, no. 4, pp. 447–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Han, F. Li, T. P. Singh, P. Wolf, and X.-J. Wang, “The pro-inflammatory role of TGFβ1: a paradox?” International Journal of Biological Sciences, vol. 8, no. 2, pp. 28–235, 2012. View at Google Scholar · View at Scopus
  78. D. Torre, R. Tambini, S. Aristodemo et al., “Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome,” Mediators of Inflammation, vol. 9, no. 3-4, pp. 193–195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Prasse, D. V. Pechkovsky, G. B. Toews et al., “A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 781–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Kreider, R. M. Anthony, J. F. Urban Jr., and W. C. Gause, “Alternatively activated macrophages in helminth infections,” Current Opinion in Immunology, vol. 19, no. 4, pp. 448–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Hesse, M. Modolell, A. C. La Flamme et al., “Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism,” The Journal of Immunology, vol. 167, no. 11, pp. 6533–6544, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Cabrera, M. Gaxiola, J. L. Arreola et al., “Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 12, pp. 2324–2338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Hironaka, I. Sakaida, Y. Matsumura, S. Kaino, K. Miyamoto, and K. Okita, “Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis,” Biochemical and Biophysical Research Communications, vol. 267, no. 1, pp. 290–295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Uchinami, E. Seki, D. A. Brenner, and J. D'Armiento, “Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis,” Hepatology, vol. 44, no. 2, pp. 420–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. T. A. Wynn and L. Barron, “Macrophages: master regulators of inflammation and fibrosis,” Seminars in Liver Disease, vol. 30, no. 3, pp. 245–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn, “Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair,” Journal of Immunology, vol. 171, no. 7, pp. 3655–3667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. K. F. Hoffmann, T. C. McCarty, D. H. Segal et al., “Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions,” The FASEB Journal, vol. 15, no. 13, pp. 2545–2547, 2001. View at Google Scholar · View at Scopus
  88. S. M. Zurawski, F. Vega Jr., B. Huyghe, and G. Zurawski, “Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction,” The EMBO Journal, vol. 12, no. 7, pp. 2663–2670, 1993. View at Google Scholar · View at Scopus
  89. T. Hage, W. Sebald, and P. Reinemer, “Crystal structure of the interleukin-4/receptor α chain complex reveals a mosaic binding interface,” Cell, vol. 97, no. 2, pp. 271–281, 1999. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Schnyder, S. Lugli, N. Feng et al., “Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain,” Blood, vol. 87, no. 10, pp. 4286–4295, 1996. View at Google Scholar · View at Scopus
  91. C. Fertin, J. F. Nicolas, P. Gillery, B. Kalis, J. Banchereau, and F. X. Maquart, “Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents,” Cellular and Molecular Biology, vol. 37, no. 8, pp. 823–829, 1991. View at Google Scholar · View at Scopus
  92. C. Ong, C. Wong, C. R. Roberts, H.-S. Teh, and F. R. Jirik, “Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma,” European Journal of Immunology, vol. 28, no. 9, pp. 2619–2629, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. D. D. Shao, R. Suresh, V. Vakil, R. H. Gomer, and D. Pilling, “Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation,” Journal of Leukocyte Biology, vol. 83, no. 6, pp. 1323–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Le Moine, V. Flamand, F.-X. Demoor et al., “Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection,” The Journal of Clinical Investigation, vol. 103, no. 12, pp. 1659–1667, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Yoshimatsu and T. Watabe, “Roles of TGF-β signals in endothelial-mesenchymal transition during cardiac fibrosis,” International Journal of Inflammation, vol. 2011, Article ID 724080, 8 pages, 2011. View at Publisher · View at Google Scholar
  96. J. C. Kovacic, N. Mercader, M. Torres, M. Boehm, and V. Fuster, “Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease,” Circulation, vol. 125, no. 14, pp. 1795–1808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Hector, H. Schäfer, S. Pöschel et al., “Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 8, pp. 914–923, 2015. View at Publisher · View at Google Scholar
  98. R. Abe, S. C. Donnelly, T. Peng, R. Bucala, and C. N. Metz, “Peripheral blood fibrocytes: differentiation pathway and migration to wound sites,” Journal of Immunology, vol. 166, no. 12, pp. 7556–7562, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Pilling, T. Fan, D. Huang, B. Kaul, and R. H. Gomer, “Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts,” PLoS ONE, vol. 4, no. 10, Article ID e7475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Ishida, A. Kimura, T. Takayasu, W. Eisenmenger, and T. Kondo, “Detection of fibrocytes in human skin wounds and its application for wound age determination,” International Journal of Legal Medicine, vol. 123, no. 4, pp. 299–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. J. F. Wang, H. Jiao, T. L. Stewart, H. A. Shankowsky, P. G. Scott, and E. E. Tredget, “Fibrocytes from burn patients regulate the activities of fibroblasts,” Wound Repair and Regeneration, vol. 15, no. 1, pp. 113–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. S. S. Maharaj, E. Baroke, J. Gauldie, and M. R. J. Kolb, “Fibrocytes in chronic lung disease—facts and controversies,” Pulmonary Pharmacology and Therapeutics, vol. 25, no. 4, pp. 263–267, 2012. View at Publisher · View at Google Scholar · View at Scopus